Stem Cell Therapy for Perianal Crohn’s Disease

Aim. To compare the effectiveness of the effect of combination therapy (local and systemic administration) with bone marrow mesenchymal stromal cells (MSC), anticlitokine therapy with infliximab (IFX), and antibiotic (AB)/immunosuppressive (IS) therapy on the frequency of healing of simple perianal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: O V Knyazev, N A Fadeeva, A V Kagramanova, N I Belyakov, N V Orlova, A A Lishchinskaya, A G Konoplyannikov, A I Parfenov
Formato: Artigo
Lenguaje:Russo
Publicado: "Consilium Medicum" Publishing house 2018-03-01
Colección:Терапевтический архив
Materias:
crohn's disease
infliximab
fistula form
mesenchymal stromal cells
stem cell therapy
Acceso en línea:https://ter-arkhiv.ru/0040-3660/article/viewFile/32743/pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares